(株)カイオム・バイオサイエンスの貸借残高情報

主市場業種証券コード/EDINET英名称
東証GRT医薬品4583/E26096Chiome Bioscience Inc.
公表日公表貸付残高前週比新規貸付成約高前週比借入残高前週比新規借入成約高前週比
2023/04/07日証協4,691,046株-3.89%1,428,100株-64.57%6,535,956株-1.48%148,452株-81.71%
2023/03/31日証協4,880,690株-39.35%4,030,600株-9.8%6,634,252株-22.57%811,800株-61.79%
2023/03/24日証協8,047,190株+72.53%4,468,700株-0.74%8,568,454株+28.14%2,124,560株+153.45%
2023/03/17日証協4,664,346株+11.7%4,501,904株+96.2%6,686,850株+4.48%838,246株+39.59%
2023/03/10日証協4,175,790株-7.18%2,294,600株+6.76%6,399,952株-0.12%600,500株+28.68%
2023/03/03日証協4,498,790株-3.6%2,149,400株-32.8%6,407,452株+0.87%466,652株+24.09%
2023/02/24日証協4,666,790株-27.29%3,198,300株-35.42%6,352,352株-19.02%376,048株-27.93%
2023/02/17日証協6,417,990株+4.08%4,952,400株+20.73%7,844,354株+1.71%521,748株-58.16%
2023/02/10日証協6,166,690株+9.93%4,102,200株-5.11%7,712,454株+4.82%1,247,000株-37.82%
2023/02/03日証協5,609,690株+36.09%4,323,200株+119.8%7,357,654株+20.11%2,005,402株+231.2%
2023/01/27日証協4,121,990株+5.9%1,966,900株+51.85%6,125,652株+1.25%605,500株+51.49%
2023/01/20日証協3,892,190株+4.71%1,295,300株+52.41%6,049,752株+2.02%399,700株-17.18%
2023/01/13日証協3,717,190株+2.98%849,900株+429.53%5,929,952株+1.35%482,600株+102.09%
2023/01/06日証協3,609,690株-3.65%160,500株-73.48%5,850,852株+24.91%238,800株-84.23%
2022/12/30日証協3,746,490株-9.92%605,300株-34.03%4,684,163株-25.52%1,514,173株+550.98%
2022/12/23日証協4,158,890株+0.65%917,500株-26.31%6,288,762株+1.01%232,600株-37.92%
2022/12/16日証協4,132,158株+1.83%1,245,084株+33.52%6,225,667株-1.27%374,660株+94.63%
2022/12/09日証協4,057,990株-1.18%932,500株+34.03%6,305,904株-0.4%192,495株+66.09%
2022/12/02日証協4,106,490株-6.15%695,752株+56.38%6,330,961株-2.04%115,900株+193.72%

※株式分割は考慮していませんのでご注意ください。

Page Top